Abstract
Cancer continues to be one of the most daunting obstacles to human health, which is why there is a never-ending attempt to create therapies that are particularly successful. For the purpose of improving treatment options and actively combating brain tumours, it is critical to have a complete comprehension of the intricate interactions that occur between cancer cells, the immune system, and therapeutic treatments. So, we suggest a model that shows how healthy cells (glial) and glioma cells (cancer cells), neurons, CD8+ T cells, macrophages, immunotherapy, and chemotherapy interact with each other by using differential equations. Positivity and boundedness are investigated. A further investigation of the analytical procedure has been carried out. Additionally, stability analysis is evaluated, and numerical simulations are provided in three different categories for the model that we have presented. A graph comparison is made between the numerical and the analytical in order to figure out the model’s quality in the discussion and conclusion. Among them, chemo-immunotherapy has emerged as a promising strategy that allows for the use of the synergistic effects of immunotherapy and chemotherapy in order to battle the development of tumours and the spread of diseases.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig9_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig10_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12597-024-00812-x/MediaObjects/12597_2024_812_Fig11_HTML.png)
Similar content being viewed by others
References
DeAngelis, L.M.: Brain tumors. N. Engl. J. Med. 344, 114–123 (2001). https://doi.org/10.1056/nejm200101113440207
Dunn, G.P., Lloyd, J.O., Robert, D.S.: The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329–360 (2004). https://doi.org/10.1146/annurev.immunol.22.012703.104803
Khajanchi, S.: Bifurcation analysis of a delayed mathematical model for tumor growth. Chaos Solitons Fract. 77, 264–276 (2015). https://doi.org/10.1016/j.chaos.2015.06.001
Philip, G., Sven, N.: The impact of phenotypic switching on glioblastoma growth and invasion. PLoS Comput. Biol. 8, 1002556 (2012). https://doi.org/10.1371/journal.pcbi.1002556
Kronik, N., Yuri, K., Vladimir, V., Zvia, A.: Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics. Cancer Immunol. Immunother. 57, 441 (2008). https://doi.org/10.1007/s00262-007-0432-y
Nandi, S., Khajanchi, S., Chatterjee, A.N., Roy, P.K.: Insight of viral infection of Jatropha curcas plant (future fuel): a control based mathematical study. Acta Anal. Funct. Appl. 13, 366–374 (2011). https://doi.org/10.3724/SP.J.1160.2011.00366
Khajanchi, S.: Modeling the dynamics of glioma-immune surveillance. Chaos Solitons Fract. 114, 108–118 (2018). https://doi.org/10.1016/j.chaos.2018.06.028
Gosak, M., Markovic, R., Jurij, D.: Network science of biological systems at different scales: A review. Phys. Life Rev. 24, 118–135 (2018). https://doi.org/10.1016/j.plrev.2017.11.003
Banerjee, S., Khajanchi, S., Chaudhuri, S.: A mathematical model to elucidate brain tumor abrogation by immunotherapy with t11 target structure. PLoS ONE 10, 0123611 (2015). https://doi.org/10.1371/journal.pone.0123611
Swanson, K., Carly, B., Murray, J.D.: Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J. Neurol. Sci. 216, 1–10 (2003). https://doi.org/10.1016/j.jns.2003.06.001
Mokhtari, R.B., Homayouni, T.S., Baluch, N.: Combination therapy in combating cancer. Oncotarget 8, 38022–38043 (2017). https://doi.org/10.18632/oncotarget.16723
Schreiber, R.D., Old, L.J., Smyth, M.J.: Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011). https://doi.org/10.1126/science.1203486
Hickey, W.F.: Basic principles of immunological surveillance of the normal central nervous system. Glia 36, 118–124 (2001). https://doi.org/10.1002/glia.1101
Iarosz, K.C., Fernando, S.B., Antonio, M.B.: Mathematical model of brain tumour with glia-neuron interactions and chemotherapy treatment. J. Theor. Biol. 368, 113–121 (2015). https://doi.org/10.1016/j.jtbi.2015.01.006
Khajanchi, S.: Stability analysis of a mathematical model for glioma–immune interaction under optimal therapy. Int. J. Nonlinear Sci. Numer. Simul. 20, 269–285 (2019). https://doi.org/10.1515/ijnsns-2017-0206
Pinho, S.T.R., Bacelar, F.S., Andrade, R.F.S.: A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy. Nonlinear Anal. Real World Appl. 14, 815–828 (2013). https://doi.org/10.1016/j.nonrwa.2012.07.034
Spratt, J.S., Spratt, T.L.: Rates of growth of pulmonary metastases and host survival. Ann. Surg. 159, 161–171 (1964). https://doi.org/10.1097/00000658-196402000-00001
Rzeski, W., Pruskil, S., Alexander, M.: Anticancer agents are potent neurotoxins in vitro and in vivo. Ann. Neurol. 56, 351–360 (2004). https://doi.org/10.1002/ana.20185
Stupp, R., et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005). https://doi.org/10.1056/nejmoa043330
Borges, F.S., Iarosz, K.C., Ren, H.P.: Model for tumour growth with treatment by continuous and pulsed chemotherapy. Biosystems 116, 43–48 (2014). https://doi.org/10.1016/j.biosystems.2013.12.001
Frederico, A.C.A., Ludmila, R.B., Lea, T.G.: Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J. Comp. Neurol. 513, 532–541 (2009). https://doi.org/10.1002/cne.21974
Kuznetsov, V., Makalkin, I., Taylor, M., Perelson, A.: Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull. Math. Biol. 56, 295–321 (1994). https://doi.org/10.1016/s0092-8240(05)80260-5
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Each contributor made an equal contribution to the paper. The article was reviewed and approved by all writers.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest declared by the authors.
Code availability
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kaviyan, E.V., Jayakumar, T., Sujitha, S. et al. Analytical and numerical solutions for glial cells interactions between ’chemo-immunotherapy and cancer’. OPSEARCH (2024). https://doi.org/10.1007/s12597-024-00812-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s12597-024-00812-x